Aurora Cannabis and Radient Technologies Announce First Commercial Delivery of Cannabis Derivatives
Aurora Cannabis Inc. (the “Company” or “Aurora”) (ACB) (ACB) ( Frankfurt : 21P; WKN: A1C4WM) and Radient Technologies Inc. (“Radient”) (TSX Venture: RTI; OTCQX: RDDTF), announced today that Aurora has taken delivery of Radient’s first commercial batch of finished cannabis derivatives, from Radient’s proprietary extraction platform. With this first batch, Radient has proven its enhanced ability to produce cannabinoid derivatives at commercial scale, and will continue to scale up production at Radient’s cannabis facility in Edmonton , reaching an expected eventual annual throughput of approximately 300,000 kg of cannabis biomass at this single location.
The partnership between Radient and Aurora was established in 2017 after the completion of a Research Joint Venture that validated Radient’s MAPTM extraction technology was capable of superior cannabinoid extraction at commercial scale. For Aurora, the relationship with Radient forms an important component of its derivative product strategy, providing a greater return on the biomass allocated for extraction, favourable cost advantages, and significantly increased extraction capacity.
– Read the entire article at Yahoo News.